[
    {
        "id": "osp-1865",
        "type": "article-journal",
        "title": "Treatment of Vaginal Atrophy with Vaginal Estrogen Cream in Menopausal Indian Women",
        "author": [
            {
                "family": "Shah",
                "given": "Maitri"
            },
            {
                "family": "Karena",
                "given": "Zalak"
            },
            {
                "family": "Patel",
                "given": "Sangita V."
            },
            {
                "family": "Parmar",
                "given": "Niyati"
            },
            {
                "family": "Singh",
                "given": "Pawan K."
            },
            {
                "family": "Sharma",
                "given": "Atul"
            }
        ],
        "URL": "https://omanscience.com/en/articles/treatment-of-vaginal-atrophy-with-vaginal-estrogen-cream-in-menopausal-indian-women",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2017
                ]
            ]
        },
        "container-title": "Oman Medical Journal",
        "DOI": "10.5001/omj.2017.03",
        "publisher": "Oman Medical Specialty Board",
        "ISSN": "1999-768X",
        "abstract": "Objectives: To measure the effect of vaginal estrogen cream in the treatment of vaginal atrophy in menopausal Indian women. Methods: A total of 50 menopausal women aged between 40 and 80 years old with symptoms of vaginal atrophy were selected and treated with 0.5 g vaginal estrogen cream, twice weekly for 12 weeks. The women were followed-up monthly where symptom score, Genital Health Clinical Evaluation (GHCE) score, vaginal pH, and vaginal maturation index (VMI) were assessed and compared to baseline data. Any adverse events were recorded. Results: There was a significant improvement (p < 0.010) in complaints such as vaginal dryness, itching, burning, and dyspareunia at the end of the study period. The clinical improvement of these patients was reflected in a decrease in GHCE score on every visit. Vaginal pH and VMI score also showed statistically significant improvements (p < 0.010). No side effects with the drugs used were recorded during the study period. Conclusions: Vaginal estrogen cream causes symptomatic relief in women of menopausal age in India suffering from vaginal atrophy."
    }
]